Pharma Giants Combine Forces to Fight New M&A Rules
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
Meet the anti-antitrust coalition.
With a looming overhaul of US merger-and-acquisition law set to reshape the economics of the M pharmaceutical industry, 31 of its biggest players -- including Merck, Amgen, Abbvie, and Gilead -- formed an alliance to fight the reforms. Their chief enemy? Khaaaaaaaaaaan!
Source Fool.com
Amgen Inc. Aktie
300,85 €
1,62 %
Rein positive Einschätzungen für Amgen Inc., nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Das Kursziel von 302 € für Amgen Inc. wurde mit dem heutigen Kurs von 300.85 € erreicht.
